EYEGATE PHARMACEUTICALS INC's ticker is EYEG and the CUSIP is 30233M107. A total of 12 filers reported holding EYEGATE PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $2,000 | -33.3% | 6,500 | 0.0% | 0.00% | -100.0% |
| Q2 2018 | $3,000 | +50.0% | 6,500 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $2,000 | -71.4% | 6,500 | 0.0% | 0.00% | -50.0% |
| Q4 2017 | $7,000 | -12.5% | 6,500 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $8,000 | -11.1% | 6,500 | 0.0% | 0.00% | -33.3% |
| Q2 2017 | $9,000 | -47.1% | 6,500 | 0.0% | 0.00% | -50.0% |
| Q1 2017 | $17,000 | +54.5% | 6,500 | 0.0% | 0.01% | +50.0% |
| Q4 2016 | $11,000 | 0.0% | 6,500 | 0.0% | 0.00% | -20.0% |
| Q3 2016 | $11,000 | -35.3% | 6,500 | 0.0% | 0.01% | -28.6% |
| Q2 2016 | $17,000 | -15.0% | 6,500 | 0.0% | 0.01% | -22.2% |
| Q1 2016 | $20,000 | +11.1% | 6,500 | 0.0% | 0.01% | 0.0% |
| Q4 2015 | $18,000 | -5.3% | 6,500 | 0.0% | 0.01% | -18.2% |
| Q3 2015 | $19,000 | – | 6,500 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |